U.S. flag

An official website of the United States government

Filters

Test type

Test purpose

Test method

Test service

Laboratory certification

Specimen type

See more specimen types...

Laboratory location

See more states

Other countries

See more countries

Results: 1 to 20 of 166

Tests names and labsConditionsGenes, analytes, and microbesMethods

von Hippel-Lindau syndrome, modifier of, 193300, Autosomal dominant (Von Hippel-Lindau disease) (CCND1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

von Hippel-Lindau syndrome, 193300, Autosomal dominant; VHL (Von Hippel-Lindau disease) (VHL gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

von Hippel-Lindau syndrome, 193300, Autosomal dominant; VHL (Von Hippel-Lindau disease) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

VHL Full Gene Analysis

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • C Sequence analysis of the entire coding region

Expedio Hereditary Cancer Predisposition Screening Assay

Kailos Genetics
United States
4031
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Guideline Panel

BioReference Health
United States
7154
  • C Sequence analysis of the entire coding region

Hereditary Cancer Screening - Colorectal & Gastric Cancer Panel (including Pancreatic Cancer) - (43 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
5843
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
4741
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
5244
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Renal/Urinary Tract Cancer Panel (Including prostate and kidney cancer) - (39 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
4039
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
10999
  • X Mutation scanning of select exons

Cystic Kidney Disease Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1644
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

High-Resolution Rapid Microarray (CGH and SNP)

Allele Diagnostics
United States
247231
  • D Deletion/duplication analysis
  • H Detection of homozygosity

Otogenetics Hereditary Cancers

Otogenetics
United States
3639
  • E Sequence analysis of select exons

Von Hippel-Lindeau Syndrome (VHL)

UAB Medical Genomics Laboratory UAB Medicine
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Von Hippel-Lindau Syndrome (VHL)

GeneKor MSA
Greece
11
  • C Sequence analysis of the entire coding region

Rapid microarray (CGH and SNP)

Allele Diagnostics
United States
247231
  • D Deletion/duplication analysis
  • H Detection of homozygosity

VON HIPPEL LINDAU SYNDROME

Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol
Spain
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

von Hippel Lindau disease

Genetic Pathology SA Pathology
Australia
31
  • D Deletion/duplication analysis
  • H Detection of homozygosity
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

Von Hippel-Lindau syndrome

Molecular Genetics Laboratory North York General Hospital
Canada
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 166

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.